Timothy J. Arens Sells 7,009 Shares of Surmodics, Inc. Stock
| ATBPF Stock | USD 0.22 0.00 0.00% |
Roughly 56% of Antibe Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Antibe Therapeutics pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Antibe Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Antibe Therapeutics stock news signals to limit their universe of possible portfolio assets.
Antibe Therapeutics pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Antibe daily returns and investor perception about the current price of Antibe Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Antibe |
Surmodics, Inc. CFO Timothy J. Arens sold 7,009 shares of the firms stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of .44, for a total value of 276,434.96. Following the completion of the sale, the chief financial officer now owns 70,350 shares
Read at thelincolnianonline.com
 |
Antibe Therapeutics Fundamental Analysis
We analyze Antibe Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Antibe Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Antibe Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Antibe Therapeutics is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Antibe Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Antibe Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Antibe Therapeutics could also be used in its relative valuation, which is a method of valuing Antibe Therapeutics by comparing valuation metrics with similar companies.
Peers
Antibe Therapeutics Related Equities
| MNOV | MediciNova | 2.99 | ||||
| ADAG | Adagene | 1.30 | ||||
| PMVP | Pmv Pharmaceuticals | 1.25 | ||||
| RZLT | Rezolute | 1.00 | ||||
| ANEB | Anebulo Pharmaceuticals | 0.70 | ||||
| MOLN | Molecular Partners | 0.17 | ||||
| AVTE | Aerovate Therapeutics | 0.38 | ||||
| PEPG | PepGen | 0.98 | ||||
| PHVS | Pharvaris | 2.06 | ||||
| HCWB | HCW Biologics | 6.00 |
Complementary Tools for Antibe Pink Sheet analysis
When running Antibe Therapeutics' price analysis, check to measure Antibe Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Antibe Therapeutics is operating at the current time. Most of Antibe Therapeutics' value examination focuses on studying past and present price action to predict the probability of Antibe Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Antibe Therapeutics' price. Additionally, you may evaluate how the addition of Antibe Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |